516 related articles for article (PubMed ID: 16351634)
21. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?
Benjamin RJ; Anderson KC
Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974
[TBL] [Abstract][Full Text] [Related]
22. [Platelet transfusion: products, indications, dose, threshold and efficacy].
Andreu G; Vasse J; Tardivel R; Semana G
Transfus Clin Biol; 2009 May; 16(2):118-33. PubMed ID: 19443257
[TBL] [Abstract][Full Text] [Related]
23. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
24. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
25. A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
Stanworth SJ; Estcourt LJ; Powter G; Kahan BC; Dyer C; Choo L; Bakrania L; Llewelyn C; Littlewood T; Soutar R; Norfolk D; Copplestone A; Smith N; Kerr P; Jones G; Raj K; Westerman DA; Szer J; Jackson N; Bardy PG; Plews D; Lyons S; Bielby L; Wood EM; Murphy MF;
N Engl J Med; 2013 May; 368(19):1771-80. PubMed ID: 23656642
[TBL] [Abstract][Full Text] [Related]
26. Platelet transfusion therapy.
Slichter SJ
Hematol Oncol Clin North Am; 1990 Feb; 4(1):291-311. PubMed ID: 2179213
[TBL] [Abstract][Full Text] [Related]
27. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
[TBL] [Abstract][Full Text] [Related]
28. Platelet transfusion strategy for hematologic cancers.
Podda GM; Ricci S
Intern Emerg Med; 2015 Feb; 10(1):81-2. PubMed ID: 25358897
[No Abstract] [Full Text] [Related]
29. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
Vamvakas EC; Hitzler WE
Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
[TBL] [Abstract][Full Text] [Related]
30. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
[TBL] [Abstract][Full Text] [Related]
31. Platelet transfusion therapy.
AuBuchon JP
Clin Lab Med; 1996 Dec; 16(4):797-816. PubMed ID: 8974196
[TBL] [Abstract][Full Text] [Related]
32. Thrombocytopenia in the neonate.
Roberts I; Stanworth S; Murray NA
Blood Rev; 2008 Jul; 22(4):173-86. PubMed ID: 18433954
[TBL] [Abstract][Full Text] [Related]
33. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials.
Cid J; Lozano M
Transfusion; 2007 Mar; 47(3):464-70. PubMed ID: 17319827
[TBL] [Abstract][Full Text] [Related]
34. Platelet transfusion goals in oncology patients.
Fasano RM; Josephson CD
Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
[TBL] [Abstract][Full Text] [Related]
35. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation.
Briggs C; Hart D; Kunka S; Oguni S; Machin SJ
Transfus Med; 2006 Apr; 16(2):101-9. PubMed ID: 16623916
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
Cameron B; Rock G; Olberg B; Neurath D
Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
[TBL] [Abstract][Full Text] [Related]
37. Clarify the negatives of the MIRASOL noninferiority trial.
Strauss RG
Transfusion; 2011 Jun; 51(6):1361-2; author reply 1362-4. PubMed ID: 21658043
[No Abstract] [Full Text] [Related]
38. The new paradigm for transfusion of platelets.
Kaufman RM
Clin Adv Hematol Oncol; 2015 May; 13(5):290-2. PubMed ID: 26352771
[No Abstract] [Full Text] [Related]
39. A consistent approach to platelet transfusion in the NICU.
Del Vecchio A; Motta M; Radicioni M; Christensen RD
J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779
[TBL] [Abstract][Full Text] [Related]
40. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.
Stanworth SJ; Hudson CL; Estcourt LJ; Johnson RJ; Wood EM;
Haematologica; 2015 Jun; 100(6):740-7. PubMed ID: 25795717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
